Pranabh Dinesh Mody
Net worth: 6 M $ as of 2026-08-30
Net worth: 6 M $ as of 2026-08-30
Pranabh Dinesh Mody is currently Non-Executive Director at Sasken Technologies Ltd. since 1991.
Current directorships include Sasken Finland Oy, Ifiunik Pharmaceuticals Ltd., Dinesh Mody Securities Pvt.
Ltd., Kumud Mody Securities Pvt Ltd., Unique Pharmaceutical Laboratories Ltd., Synit Drugs Pvt Ltd., Atma Leather Pvt Ltd., and Eragon Ventures Ltd. Former roles include President & Executive Director at J.B. Chemicals & Pharmaceuticals Ltd. from 2009 to 2020 and Director at Biotech Laboratories (Pty) Ltd. Education includes an MBA from Oakland University (Michigan) conferred in 1986 and an undergraduate degree from Bombay College of Pharmacy conferred in 1984.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-29 | 288,547 ( 1.9% ) | 6 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| SASKEN TECHNOLOGIES LIMITED | Director/Board Member | 1991-07-28 |
Dinesh Mody Securities Pvt. Ltd. | Director/Board Member | 2011-09-05 |
Ifiunik Pharmaceuticals Ltd. | Director/Board Member | 2011-09-05 |
Kumud Mody Securities Pvt Ltd. | Director/Board Member | 2011-09-05 |
Synit Drugs Pvt Ltd. | Director/Board Member | 2011-09-05 |
Unique Pharmaceutical Laboratories Ltd.
Unique Pharmaceutical Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Director/Board Member | 2011-09-05 |
Sasken Finland Oy
Sasken Finland Oy Specialty TelecommunicationsCommunications Provides hardware and software solutions for wireless technology | Director/Board Member | - |
Eragon Ventures Ltd.
Eragon Ventures Ltd. Eragon Ventures Ltd. was founded in 1977. The private company is based in Mumbai, India. Eragon Ventures is a family office operated by former promoters of J.B. Chemicals and Pharmaceuticals, conducting investments across a variety of asset classes and providing long-term capital to support entrepreneurial growth. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| J. B. CHEMICALS & PHARMACEUTICALS LIMITED | President | 2020-11-09 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
J.B. Chemicals & Pharmaceuticals Ltd.
J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals products | Health Technology |
Oakland University (Michigan)
Oakland University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sasken Technologies Ltd.
Sasken Technologies Ltd. Information Technology ServicesTechnology Services Provides software services | Technology Services |
Sasken Finland Oy
Sasken Finland Oy Specialty TelecommunicationsCommunications Provides hardware and software solutions for wireless technology | Communications |
Ifiunik Pharmaceuticals Ltd. | |
Biotech Laboratories (Pty) Ltd.
Biotech Laboratories (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and branded pharmaceuticals | Health Technology |
Dinesh Mody Securities Pvt. Ltd. | |
Kumud Mody Securities Pvt Ltd. | |
Unique Pharmaceutical Laboratories Ltd.
Unique Pharmaceutical Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Synit Drugs Pvt Ltd. | |
Bombay College of Pharmacy
Bombay College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eragon Ventures Ltd.
Eragon Ventures Ltd. Eragon Ventures Ltd. was founded in 1977. The private company is based in Mumbai, India. Eragon Ventures is a family office operated by former promoters of J.B. Chemicals and Pharmaceuticals, conducting investments across a variety of asset classes and providing long-term capital to support entrepreneurial growth. |
Select your edition
All financial news and data tailored to specific country editions